Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · USD

$4.03

+0.39 (+10.7%)· Recorded snapshot

Market cap	8.5M
Revenue (ttm)	194K
Net income (ttm)	-7.7M
EPS (ttm)	-$5.14
Shares out	2.1M
Volume	32,034.84
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 194K
Net income (ttm): -7.7M
EPS (ttm): -$5.14
Market cap: 8.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-162.8

P25 n/aP50 n/aP75 n/a

ROIC-96.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LEXX indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001348362
Company name	Lexaria Bioscience Corp.
Country	Canada
Country code	US
CUSIP number	52886N604
Earnings date	2026-11-27
Earnings time	bmo
Employees	7
Employees change	2
Employees growth	40%
Enterprise value	$5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-05-31
First seen	2026-05-09
Fiscal year end	August
Founded	2004
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US52886N6040
Last 10-K release date	2025-11-28
Last earnings date	2026-07-13
Last refreshed	2026-11-04
Last stock split date	2026-08-03
Last stock split type	Reverse
Market cap	$8.5M
Market cap category	Nano-Cap
Next earnings date	2026-11-27
Options	No
Price	$4.03
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	LEXX
Website	https://lexariabioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-127.62%
EV/Sales	25.56x
FCF / EV yield	-150.56%
FCF yield	-87.95%
P/B ratio	1.41x
P/S ratio	43.76x
Price / tangible book value	1.93x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-3,862.94%
Pretax margin	-3,987.65%
Profit per employee	$-1.1M
Revenue per employee	$27,714
ROA	-81.3%
ROA (5Y)	-65.6%
ROCE	-170.4%
ROE	-162.77%
ROE (5Y)	-123.84%
ROIC	-96.43%
SBC / revenue	188.38%
Tax / revenue	2.27%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	0
Gross profit growth	-68.36%
Gross profit growth 3Y	-6.04%
Gross profit growth 5Y	-20.1%
Net income growth quarters	3
Net income growth years	0
Revenue growth	-68.5%
Revenue growth 10Y	18.09%
Revenue growth 3Y	-14.15%
Revenue growth 5Y	-23.81%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-40,817
Depreciation and amortization	$76,573
EBIT	$-7.5M
EBITDA	$-7.4M
EPS	$-5.14
FCF per share	$-3.54
Financing cash flow	$6.5M
Free cash flow	$-7.5M
Free cash flow minus SBC	$-7.8M
Gross profit	$194,000
Income taxes	$4,403
Investing cash flow	$-243,975
Net cash flow	$-1.1M
Net income	$-7.7M
Operating cash flow minus SBC	$-7.8M
Operating income	$-7.5M
Revenue	$194,000
Stock-based compensation	$365,458

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.43
Book value per share	$2.87
Debt / equity	0.02
Long-term assets	$716,462
Long-term liabilities	$53,679
Net cash (debt)	$3.5M
Net cash / market cap	41.59%
Net cash growth	-21.7%
Net debt / equity	-0.81
Piotroski F-Score	3
Property, plant and equipment	$313,432
Shareholders' equity	$4.3M
Tangible book value	$4.4M
Tangible book value per share	$2.66
Total assets	$4.8M
Total cash	$3.6M
Total debt	$86,714
Total liabilities	$437,091
WACC	7.48%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.03
Current assets	$4.1M
Current liabilities	$383,412
Current ratio	10.6
Net working capital	$97,386
Quick ratio	9.56
Working capital	$3.7M
Working capital turnover	0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-32.4%
Dividend yield	0%
Shareholder yield	-32.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-96.91%
10Y return CAGR	-29.38%
10Y total return	-96.91%
150-day SMA	$8.22
15Y price change	-96.21%
15Y return CAGR	-19.6%
15Y total return	-96.21%
1D price change	10.71%
1M price change	39.93%
1M total return	39.93%
1W price change	25.16%
1W total return	25.16%
1Y price change	-73.66%
1Y return CAGR	-73.68%
1Y total return	-73.66%
20-day SMA	$3.16
200-day SMA	$8.88
20Y price change	-99.3%
20Y return CAGR	-21.95%
20Y total return	-99.3%
3M price change	-31.29%
3M total return	-31.29%
3Y price change	-81.21%
3Y return CAGR	-42.72%
3Y total return	-81.21%
50-day SMA	$4.99
50-day SMA vs 200-day SMA	50under200
52-week high	$21.60
52-week high date	2025-12-12
52-week low	$2.43
52-week low date	2026-10-19
5Y price change	-95.71%
5Y return CAGR	-46.73%
5Y total return	-95.71%
6M price change	-62.23%
6M total return	-62.23%
After-hours change	-1.74%
After-hours close	$4.03
After-hours price	$3.96
All-time high	$2,700.00
All-time high date	2007-10-10
All-time low	$2.43
All-time low date	2026-10-14
Average true range (ATR)	$0.55
Average volume	57.2K
Beta (1Y)	0.78
Beta (2Y)	0.63
Beta (5Y)	0.6
Change from 52-week high	-81.34%
Change from 52-week low	65.84%
Change from all-time high	-99.85%
Change from all-time low	65.84%
Change from open	6.33%
Day's gap	4.12%
Dollar volume	$129,100
High price	$4.10
Low price	$3.70
Monthly RSI	37.15
Open price	$3.79
Position in 52-week range	82.5%
Premarket change	4.22%
Premarket close	$4.03
Premarket price	$4.20
Premarket volume	2.6K
Previous close	$3.64
Price vs 150-day SMA	-50.98%
Price vs 20-day SMA	27.45%
Price vs 200-day SMA	-54.63%
Price vs 50-day SMA	-19.3%
Relative volume	0.56
RSI	55.81
Sharpe ratio	-0.39
Sharpe ratio (3Y)	0.12
Sharpe ratio (5Y)	-0.16
Sortino ratio	-0.47
Sortino ratio (3Y)	0.22
Sortino ratio (5Y)	-0.17
Volume	32K
Weekly RSI	41.84
YTD price change	-56.46%
YTD total return	-56.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.1M
Float percentage	97.63%
Shares change (QoQ)	1.48%
Shares change (YoY)	32.4%
Shares held by insiders	1.31%
Shares held by institutions	5.09%
Shares outstanding	2.1M
Short % of float	12.44%
Short % of shares	12.14%
Short ratio	3.3 days

Deeper analysis on LEXX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LEXX report

Is a complete LEXX research report available?

No complete published report is available for Lexaria Bioscience Corp. (LEXX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Lexaria Bioscience Corp. (LEXX)

Price

Financial snapshot

Fair-value bridge

Latest news · LEXX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LEXX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LEXX

Frequently asked questions